Case reports and small series associate concurrent azoles (including posaconazole) with increased neurotoxicity, notably autonomic neuropathy and constipation, likely via CYP3A4 inhibition [7,24]. The gene discussed is CYP3A4; the disease is autonomic neuropathy.